share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  08/01 15:37

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 5,295 shares of common stock on 08/01/2024, with an aggregate market value of $2,689,860. The shares were originally acquired on the same date through an option granted on 06/01/2017 from the issuer. The transaction will be conducted in cash. This follows a previous sale of 7,073 shares in the past three months, which grossed $3,168,704.
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 5,295 shares of common stock on 08/01/2024, with an aggregate market value of $2,689,860. The shares were originally acquired on the same date through an option granted on 06/01/2017 from the issuer. The transaction will be conducted in cash. This follows a previous sale of 7,073 shares in the past three months, which grossed $3,168,704.
Vertex Pharmaceuticals Inc.董事Bruce I. Sachs將於2024年08月01日賣出5295股普通股,市值爲2689860美元。這些股票原本是通過2017年06月01日發放的期權獲得的。此次交易將以現金方式進行。此前三個月曾經賣出7073股,總共獲得3168704美元。
Vertex Pharmaceuticals Inc.董事Bruce I. Sachs將於2024年08月01日賣出5295股普通股,市值爲2689860美元。這些股票原本是通過2017年06月01日發放的期權獲得的。此次交易將以現金方式進行。此前三個月曾經賣出7073股,總共獲得3168704美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息